Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PuraPharm Corp. Ltd. ( (HK:1498) ) has issued an announcement.
PuraPharm Corporation Limited has announced a delay in the dispatch of a circular related to the Patent Licence Agreement and Subscription Agreement. Initially scheduled for release by August 15, 2025, the circular will now be dispatched by October 17, 2025, due to the need for additional time to finalize its contents. This postponement may impact the company’s stakeholders as it involves significant agreements and transactions.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on the development and distribution of herbal medicines and related healthcare products.
Average Trading Volume: 195,586
Technical Sentiment Signal: Sell
Current Market Cap: HK$177.7M
Find detailed analytics on 1498 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money